Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Is this relevant to us?
https://backend.otcmarkets.com/otcapi/company/financial-report/291431/content
Yeppers
I have about the same number of shares you do
No info on pg.en on otc market site. Found article below, sorry if it's already been posted
https://topnewsguide.com/2021/07/07/regen-biopharma-inc-otcmkts-rgbp-share-going-up-the-charts-again/
Between now and my bday Aug 11.
#2
Safe travels
"The Company's established portfolio of licensing agreements is expected to allow the company the ability to develop its own innovations to stand out amongst its peers."
News... Onph
Oncology Pharma, Inc. is Entering Into the Next Phase of its Growth and Expansion PhasePress Release | 06/30/2021
SAN FRANCISCO, CA / ACCESSWIRE / June 30, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the "Company") is developing a program to establish the use of its license utilizing NR2F6 agonists and antagonists coupled with the proprietary drug delivery systems in the treatment of various disorders including human pancreatic cancer and colon cancer. The work the Company is contracting to conduct is intended to do pre-clinical trials leading into seeking FDA approval for the combined efforts. Our team of industry experts and advisors have the expertise to lead the Company to efficiently conduct this next phase of development.
The developing program will allow Oncology Pharma to begin its own path towards producing proprietary intellectual property, for the pursuit and development of new therapies. The Company's established portfolio of licensing agreements is expected to allow the company the ability to develop its own innovations to stand out amongst its peers.
Also works with CELZ
News from Onph...
SAN FRANCOSCO, CA / ACCESSWIRE / June 15, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the 'Company') has been continuing its research and work reviewing and implementing collaboration between its interests in therapy, delivery and trial experience amongst its licensed products. The Company is in the early stages of reviewing the work and exploring opportunities between the synergistic value of its licensed Intellectual Properties and applying its expertise towards advancing the licensed IP we have with NanoSmart, Sybleu, Regen Biopharma and Ribera Solutions. The Company believes that it can take advantage internally of economies of scale and new IP can be created through a combination of therapies and delivery mechanisms.
In addition to seeking ways to enhance value with its existing portfolio of assets, Oncology Pharma has begun discussions within its network to identify key players to implement its goals. Being able to produce its own intellectual properties would be a key building block in the Company's objective towards expansion.
Oncology Pharma will further be looking into potentially utilizing a single CRO (Clinical Research Organization), in conjunction with its expertise within the Company, which management believes will save time and expense in getting the IP through the next steps of its development.
You enjoying this beautiful Midwestern morning?
SCHEDULE AN APPOINTMENT
?
PROFESSOR OF NEUROSCIENCES
Santosh Kesari, M.D., Ph.D.
Chair, Department of Translational Neurosciences
Director of Neuro-oncology
310-829-8265 SANTOSH.KESARI@PROVIDENCE.ORG
About Us Santosh Kesari, M.D., Ph.D.
Dr. Santosh Kesari is a board-certified neurologist and neuro-oncologist and is currently Chair and Professor, Department of Translational Neuro-oncology and Neurotherapeutics, Saint John’s Cancer Institute.
He is also Director of Neuro-oncology at Pacific Neuroscience Institute, Providence Saint John’s Health Center and Providence Little Company of Mary Medical Center Torrance, and leads the Pacific Neuroscience Research Center at Pacific Neuroscience Institute.
Dr. Kesari is ranked among the top 1% of neuro-oncologists and neurologists in the nation, according to Castle Connolly Medical Ltd and an internationally recognized scientist and clinician.
He is a winner of an Innovation Award by the San Diego Business Journal. He is on the advisory board of American Brain Tumor Association, San Diego Brain Tumor Foundation, Chris Elliott Fund, Nicolas Conor Institute, Voices Against Brain Cancer, and Philippine Brain Tumor Alliance. He has been the author of over 250 scientific publications, reviews, or books.
He is the inventor on several patents and patent applications, and founder and advisor to many cancer and neurosciences focused biotech startups. In addition, he is a member of the Los Angeles Biomedical Research Institute.
Dr. Kesari has had a long-standing interest in cancer stem cells and studies their role in the formation of brain tumors and resistance to treatment. He believes that in order to cure patients with brain tumors we first need to gain a better molecular and biological understanding of the disease. A physician/scientist, Kesari harnesses his experience in surgery, chemotherapy, immunotherapy, radiation therapy and novel devices to help develop Precision Therapeutic Strategies that will advance medicine to a new stage in the battle against brain tumors and eradicate the disease.
This guy.... Dr. Kesari is ranked among the top 1% of neuro-oncologists and neurologists in the nation, according to Castle Connolly Medical Ltd and an internationally recognized scientist and clinician.
I hope so.
You know we got something when a company locks up a 15 year deal. You ain't going to do something like that in the hopes of nothing coming out of it. That is what has made me a believer in this Co. That and the other patents, IP.
I'm thinking min $. 50, max$3.00(12 billion plus market cap)
Thanks Skiluc
Thanks for keeping it real!
I like your opinion, thank you!
Roameo, Roameo wherefore art thou Roameo?
Just got back from vacation not sure if this has been posted.
https://www.sec.gov/Archives/edgar/data/1589150/000160706221000145/rgbp053121form8k.htm
Back at ya brother!
yeah it is
The onph news along with the rgbp Sec of State filing is a nice combo!
https://www.filingre.com/stock/RGBP
Somebody subscribe to confirm, all my money is in this
Nice find
I appreciate it!
Finding true gems like this aren't for flipping. You stick with the smart choice. Patience pays off!
Just joking with them. I usually find news but don't read it just get it on the board so others can decipher if I can't.
Hope that's what you meant.
Thanks twice
I do the finding you do the reading between the lines, lol.
Thanks bud!
News out on Oncology...Not sure if it relates to us or not.
Oncology Pharma, Inc. Is Pursuing the Development of Its Small Molecule Drug for the Treatment of Colon Cancer
Yeah every morning, scrolling and looking for every bit of info, news.
Papa needs a new pair of shoes.
Thanks, just found was about to post.
Awfully nice company to be in a list with!
My thoughts as well.
Can't argue with you on that
Bad link(scroll down) but there is news
Found it on otc markets.com.
ADHC’s CRYPTOCURRENCY NEWS PORTAL,www.CRYPTOCURRENCYBUSINESSNOW.com,
THE COMPANY’S INNOVATIVE NEW CRYPTOCURRENCY NEWS AND INFORMATION SITE TO TARGET
EXPLODING $2.4 TRILLION CRYPTOCURRENCY MARKET
Del Mar, CA (5-10-21)
Universal Wellness Holding Corporation (OTC: ADHC") announced today that the company has unveiled
a news and information ecommerce site focused on the $2.4 trillion cryptocurrency market.
www.CryptoCurrencyBusinessNow.com (CCBN) is innovative ecommerce site that will focus on the
massive number of new investors seeking insight into exploding this exploding market.
CCBN has outlined four revenues streams 1. Charging Content providers 2. Banner Ad Revenue 3.
Affiliate Marketing 4. Cryptocurrency marketing and advisory services.
More details on these four revenue streams will be announced after the "GRAND OPENING"
Wednesday.
THE CRYPTO CURRENCY MARKET
The Cryptocurrency Market lead by a 46% Bitcoin dominance represents over $2.4 trillion in market
capitalization. The market consists of over 5900 cryptocurrencies traded on 19,000 markets (Exchanges)
with a daily volume of over $676 billion. (see www.Coinlore.com). Recently, Tesla Motors (Nasdaq:
"TSLA") announce a purchase of a $1.5 billion worth of bitcoin. Recently DOGECOIN and ETHEREUM
have made big runs in price as the cryptocurrency industry is gaining more and more attention in the
traditional financial community, including payment apps like PayPal, Venmo and Visa/Mastercard.
CryptoCurrencyBusinessNow.com will be unveiled Monday May 10, 2021 in a preliminary form with the
full site with all functionality to be unveiled in a "GRAND OPENING" later in the week on Wednesday
May 12.
The recently revamped site in the Cannabis sector www.CannaBusinessNow.com (CBN) has seen a major
spike in traffic since its initial launch. The traffic continues to rise and was up over 1100% last week
generating over 10,000 users per month. The company plans on continuing the momentum by
producing content that directly impacts those who are seeking a trusted online source while searching
for the latest breakthroughs in modern CBD health and wellness.
Bringing that same level of traffic and interest to the cryptocurrency business is the focus of
CryptoBusinessNow and the Company is seeking to engage top level trading platforms as advertisers and
partners driving traffic to these established sites.
ADHC will be issuing a complete shareholder update in the next few days fully detailing the revenue
model for both ecommerce platforms.
In additional news ADHC expects to close the recently announced cryptocurrency acquisition on Monday
May 17th. This acquisition is expected to bring more than $20mm in crypto currency assets to ADHC's financial picture.
ABOUT UNIVERSAL WELLNESS HOLDING CORP (PREVIOUSLY NAME: AMERICAN DIVERSIFIED HOLDINGS
CORPORATION, (OTC: "ADHC") Twitter @univcrypto www.UniversalWellnesshc.com
Universal Wellness Holding has unveiled a new Ecommerce business on 4-7-2012
www.UniversalWellnesshc.com The company previously announced two Letters of Intent to acquire
leading companies in the CBD sector. Interested parties can refer to our previous news releases on
www.otcmarkets.com for more information on those companies as due diligence process continues.
Based upon latest information from www.otcmarkets.com Universal Wellness Holding Corp (OTC:
"ADHC") currently has:
866 million shares outstanding
330 million shares in the float
Shareholders should be aware that Universal Wellness Holding Corporation (OTC: "ADHC") only
distributes information via www.otcmarkets.com news release section. No other prior news sources
including prior 8k filings or other prior news releases distributed through other news outlets should be
relied upon as official news from the company.
Universal Wellness Holding Corporation is not planning to reverse split the stock.
ABOUT Universal Wellness Holding Corp (0TC "ADHC")
Universal Wellness Holding Corp (OTC: ADHC) is a publicly traded holding company trading under the
ticker symbol ("ADHC"). Until the new ticker and name changed are approved information on ADHC can
be found on otcmarkets.com under American Diversified Holdings Corporation.
ADHC NEW SHAREHOLDER COMMUNICATION LINE: 657-999-4225
Information contained herein includes forward-looking statements. These statements relate to future
events or future financial performance, involving known and unknown risks and uncertainties that may
cause our actual results to be materially different performance or achievements expressed. You should
not place undue reliance on these statements since they involve known and unknown risks, in some
cases, beyond our control may affect actual results. Any forward-looking statement reflects our current
views with respect to future events and is subject to uncertainties.